Tag: Venous disease
FDA approves IDE for pivotal study of high-intensity focused ultrasound platform
The Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application for the VEINRESET multicenter pivotal study that will evaluate Sonovein...
Venous stenting: “We need to evaluate use, appropriateness and clinical indication”
An analysis of venous stent usage trends in the USA from 2014 to 2021 showed a “significant increase” in stents per day placed over...
“Value for money is mandatory”—challenging questions on best treatment, cost-effectiveness and...
Speaking to Venous News at VEITHsymposium 2022 (15–19 November, New York, USA) Armando Mansilha (Porto, Portugal) answers the “challenging question” of how to best...
AVF 2023: Investigators report update on three-year first-in-human results for bioprosthetic...
Researchers in Colombia behind the first-in-human study of a novel bioprosthetic venous valve designed to treat chronic venous insufficiency (CVI) reported three-year results among...
New study indicates cost-effectiveness of Denali IVC filter over Option device
Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter (BD) than with the Option...
Overtreatment in venous disease: Financial incentives are “the elephant in the...
To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...
Select gene single nucleotide polymorphisms found to be associated with venous...
Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...
AVF 2022: VenoValve improvement “maintained” for 2.5 years without adverse events
Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum...
Registry data show greater clot chronicity on postprocedure inspection than initially...
Nearly half of patients deemed preprocedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
Telehealth ‘will change the future of venous practice’ post COVID-19
Six venous specialists, Manj Gohel (Cambridge, UK), Ian Franklin (London, UK) Alun Davies (London, UK), Sriram Narayanan (Singapore), Raghu Kolluri (Columbus, USA)...
COVID-19: what will be the fallout for patients with venous disease?
Manj Gohel, Stephen Black and Alun Davies consider the impact of the COVID-19 pandemic on patients with venous disease. They conclude: "Once the acute...
Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness
As a podium talk at the annual meeting of the American Venous Forum (VENOUS 2020; 3–6 March, Amelia Island, USA), it represented a bit...